NCT01011959 - A Multiple-dose Study of the Safety and Tolerability of REGN88(SAR153191) in Rheumatoid Arthritis Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

REGN88

This study will be conducted in 3 parts, and will include a total of 6 dose cohorts. Part B will not begin until the safety of Part A has been assessed. Part C will begin when enrollment into Part B is complete.

Trial Locations (24)

Unknown

Santa Maria

Boca Raton

Clearwater

Daytona Beach

Delray Beach

Palm Harbor

Idaho Falls

Worcester

Lansing

Flowood

Kalamzaoo

St Louis

Reno

Charlotte

Cincinnati

Toledo

Oklahoma City

Duncansville

Greenville

Orangeburg

Hixson

Austin

Houston

San Antonio